Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer


Michelle M. Hanna

Michelle M. Hanna

Founder and CEO
Ribomed Biotechnologies


Dr. Hanna, the founder and CEO of Ribomed Biotechnologies, received her Ph.D. in Chemistry from the University of California, Davis and did her postdoctoral work in Biochemistry and Molecular Genetics as an American Cancer Society Postdoctoral Fellow at the University of California, Berkeley. She was an Assistant Professor of Biological Chemistry at the University of California Irvine College of Medicine, where she received Young Investigator awards from the American Cancer Society and the Beckman Foundation, and an Associate Professor of Biochemistry until she founded Ribomed. Dr. Hanna is the inventor of the Abscription/CAPS technology. She has been awarded over $10 million in grants and contracts and her work has resulted in numerous publications and patents. Dr. Hanna also serves on the Grant Review Board for Praespero, an autoimmune disease foundation.

Research Interest

genetics, genetics disorders, cancer biology